tiprankstipranks
Trending News
More News >
NDT Pharmaceuticals, Inc. (NDTP)
OTHER OTC:NDTP
US Market

NDT Pharmaceuticals (NDTP) Income Statement

Compare
11 Followers

NDT Pharmaceuticals Income Statement

Last quarter (Q3 2025), NDT Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, NDT Pharmaceuticals's net income was $-9.22K. See NDT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
$ 0.00
Gross Profit
$ 0.00
Operating Expenses
$ 25.17K
Depreciation and Amortization
$ 167.90K
EBITDA
$ 88.87K
Operating Income
$ -25.17K
Other Income/Expenses
$ -53.86K
Pretax Income
$ -79.03K
Net Income
$ -79.03K
Per Share Metrics
Basic EPS
$ 0.00
Diluted EPS
$ 0.00
Weighted Average Shares Outstanding
160.00M
Weighted Average Shares Outstanding (Diluted)
160.00M
Currency in USD

NDT Pharmaceuticals Earnings and Revenue History